Income Statement Instituto Rosenbusch S.A.

Stocks

ROSE

ARROSE010025

Pharmaceuticals

End-of-day quote Buenos Aires S.E. 10/09/2026			5-day change	1st Jan Change
155.00 ^ARS	+0.65%		-1.59%	-35.55%

06/08	Instituto Rosenbusch S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
10/04	Instituto Rosenbusch S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

f46b4ab1ec7fc.LKIj2kSOIT4ZljQIjJe6zphLKiaDTJ8H4jKto-Qu90c.ee5nvy3ocGx62lJ92vrwg88YfG3xNq9ulUPbxKJtpwFU9U_oBsJxfX7AeQ

Published financial data: INSTITUTO ROSENBUSCH S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Revenues	78Cr	137.31Cr	452.81Cr	827.49Cr	640.36Cr
Total Revenues	78Cr	137.31Cr	452.81Cr	827.49Cr	640.36Cr
Cost of Goods Sold, Total	56Cr	74Cr	323.1Cr	448.89Cr	668.96Cr
Gross Profit	22Cr	63Cr	129.71Cr	378.6Cr	-29Cr
Selling General & Admin Expenses, Total	20Cr	34Cr	115.59Cr	184.59Cr	244.87Cr
Other Operating Expenses	-51.38L	2.8Cr	13Cr	6.96Cr	63Cr
Other Operating Expenses, Total	20Cr	37Cr	128.13Cr	191.54Cr	308.3Cr
Operating Income	2.16Cr	27Cr	1.58Cr	187.06Cr	-336.91Cr
Interest Expense, Total	-3.46Cr	-17Cr	-49Cr	-63Cr	-165.07Cr
Interest And Investment Income	-	-	-	-	2L
Net Interest Expenses	-3.46Cr	-17Cr	-49Cr	-63Cr	-165.05Cr
Currency Exchange Gains (Loss)	-5.85Cr	-10Cr	78Cr	-266.37Cr	56Cr
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-7.16Cr	-33.75L	31Cr	-141.87Cr	-446.31Cr
Gain (Loss) On Sale Of Assets	-	-	32Cr	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	5.2Cr	1.39Cr	-	-	-
EBT, Incl. Unusual Items	-1.96Cr	1.05Cr	63Cr	-141.87Cr	-446.31Cr
Income Tax Expense	43.28L	2.41Cr	6.19Cr	19Cr	5.09Cr
Earnings From Continuing Operations	-2.39Cr	-1.36Cr	57Cr	-160.52Cr	-451.4Cr
Net Income to Company	-2.39Cr	-1.36Cr	57Cr	-160.52Cr	-451.4Cr
Minority Interest	43.22L	54.71L	-49.4L	19Cr	-8.37Cr
Net Income - (IS)	-1.96Cr	-80.98L	56Cr	-141.73Cr	-459.77Cr
Net Income to Common Incl Extra Items	-1.96Cr	-80.98L	56Cr	-141.73Cr	-459.77Cr
Net Income to Common Excl. Extra Items	-1.96Cr	-80.98L	56Cr	-141.73Cr	-459.77Cr
Per Share Items
Net EPS - Basic	-0.46	-0.19	13.22	-33.28	-107.95
Basic EPS - Continuing Operations	-0.46	-0.19	13.22	-33.28	-107.95
Basic Weighted Average Shares Outstanding	4.26Cr	4.26Cr	4.26Cr	4.26Cr	4.26Cr
Net EPS - Diluted	-0.46	-0.19	13.22	-33.28	-107.95
Diluted EPS - Continuing Operations	-0.46	-0.19	13.22	-33.28	-107.95
Diluted Weighted Average Shares Outstanding	4.26Cr	4.26Cr	4.26Cr	4.26Cr	4.26Cr
Normalized Basic EPS	-0.95	0.08	4.5	-16.41	-67.46
Normalized Diluted EPS	-0.95	0.08	4.5	-16.41	-67.46
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	4.47Cr	32Cr	12Cr	203.11Cr	-317.7Cr
EBITA	2.16Cr	27Cr	2.32Cr	188.79Cr	-336.91Cr
EBIT	2.16Cr	27Cr	1.58Cr	187.06Cr	-336.91Cr
Effective Tax Rate - (Ratio)	-22.12	229.42	9.83	-13.14	-1.14
Total Current Taxes	43.28L	2.41Cr	6.19Cr	19Cr	5.09Cr
Normalized Net Income	-4.04Cr	33.62L	19Cr	-70Cr	-287.32Cr
Supplemental Operating Expense Items
Advertising Expense	22.29L	30.66L	98.39L	1.27Cr	1.05Cr
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	8.73Cr	16Cr	51Cr	83Cr	91Cr
General and Administrative Expenses	12Cr	18Cr	64Cr	101.58Cr	154.22Cr
Maintenance & Repair Expenses, Total	2.65Cr	2.9Cr	9.75Cr	10Cr	14Cr

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Assets
Cash And Equivalents	5.7Cr	11Cr	39Cr	88Cr	71Cr
Total Cash And Short Term Investments	5.7Cr	11Cr	39Cr	88Cr	71Cr
Accounts Receivable, Total	15Cr	24Cr	70Cr	150.05Cr	119.52Cr
Other Receivables	5.28Cr	8.9Cr	66Cr	34Cr	73Cr
Notes Receivable	-	-	-	-	-
Total Receivables	20Cr	33Cr	136.36Cr	184.44Cr	192.68Cr
Inventory	30Cr	53Cr	218.68Cr	313.72Cr	260.77Cr
Other Current Assets, Total	31.59L	3.61Cr	1.6Cr	3.86Cr	49Cr
Total Current Assets	56Cr	100.13Cr	395.72Cr	589.73Cr	573.3Cr
Gross Property Plant And Equipment	145.69Cr	287.04Cr	925.85Cr	1.82TCr	2.36TCr
Accumulated Depreciation	-127.13Cr	-254.19Cr	-819.38Cr	-1.65TCr	-2.16TCr
Net Property Plant And Equipment	19Cr	33Cr	106.47Cr	162.89Cr	199.21Cr
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	48.43T	32.5L	1.35Cr	0	0
Other Long-Term Assets, Total	55.99L	1.5Cr	74.27L	1.58Cr	2.04Cr
Total Assets	75Cr	134.8Cr	504.28Cr	754.2Cr	774.55Cr
Liabilities
Accounts Payable, Total	8.81Cr	14Cr	83Cr	49Cr	76Cr
Accrued Expenses, Total	10Cr	29Cr	34Cr	142.36Cr	385.23Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	1.88Cr	4.89Cr	44Cr	95Cr	52Cr
Current Income Taxes Payable	68.46L	3.66Cr	7.84Cr	3.57Cr	10Cr
Other Current Liabilities	6.44Cr	3.6Cr	21Cr	39Cr	137.12Cr
Total Current Liabilities	28Cr	55Cr	188.68Cr	329.08Cr	660.53Cr
Long-Term Debt	17Cr	30Cr	60Cr	79Cr	93Cr
Deferred Tax Liability Non Current	1.33Cr	1.33Cr	1.33Cr	1.33Cr	1.33Cr
Other Non Current Liabilities	8.44Cr	9.21Cr	46Cr	41Cr	72Cr
Total Liabilities	55Cr	95Cr	295.44Cr	450.89Cr	827.16Cr
Common Stock, Total	4.26Cr	4.26Cr	4.26Cr	4.26Cr	4.26Cr
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	-23Cr	-45Cr	-85Cr	-326.54Cr	-889.33Cr
Comprehensive Income and Other	36Cr	77Cr	272.05Cr	606.52Cr	805.05Cr
Total Common Equity	18Cr	36Cr	191.45Cr	284.24Cr	-80Cr
Minority Interest	2.22Cr	3.77Cr	17Cr	19Cr	27Cr
Total Equity	20Cr	40Cr	208.83Cr	303.31Cr	-53Cr
Total Liabilities And Equity	75Cr	134.8Cr	504.28Cr	754.2Cr	774.55Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.26Cr	4.26Cr	4.26Cr	4.26Cr	4.26Cr
ECS Total Common Shares Outstanding	4.26Cr	4.26Cr	4.26Cr	4.26Cr	4.26Cr
Book Value / Share	4.16	8.52	44.95	66.74	-18.79
Tangible Book Value	18Cr	36Cr	190.1Cr	284.24Cr	-80Cr
Tangible Book Value Per Share	4.16	8.44	44.64	66.74	-18.79
Total Debt	19Cr	34Cr	103.38Cr	174.03Cr	145Cr
Net Debt	13Cr	24Cr	64Cr	86Cr	74Cr
Minority Interest, Total (Incl. Fin. Div)	2.22Cr	3.77Cr	17Cr	19Cr	27Cr
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	14Cr	23Cr	119.75Cr	132.79Cr	123.05Cr
Inventories - Work In Process, Total	4.71Cr	4.4Cr	17Cr	35Cr	56Cr
Inventories - Finished Goods, Total	11Cr	23Cr	82Cr	139.44Cr	82Cr
Inventories - Others	-	2.55Cr	-	6.64Cr	-
Machinery, Total	79Cr	158.91Cr	506.94Cr	1.02TCr	1.31TCr
Accumulated Allowance for Doubtful Accounts (Supple)	70.24L	59.06L	3.9Cr	2.77Cr	3.71Cr

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Net Income	-1.96Cr	-80.98L	56Cr	-141.73Cr	-459.77Cr
Depreciation & Amortization - CF	2.31Cr	4.89Cr	9.95Cr	14Cr	19Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	11.33L	74.27L	1.73Cr	-
Depreciation & Amortization, Total	2.31Cr	5Cr	11Cr	16Cr	19Cr
Amortization of Deferred Charges, Total - (CF)	48.43T	94.34T	-	-	-
Minority Interest in Earnings - (CF)	-43.22L	-54.71L	5.64Cr	-19Cr	2.31Cr
Asset Writedown & Restructuring Costs	-	2L	7.72Cr	76Cr	-
Other Operating Activities, Total	93.7L	3.23Cr	8.82Cr	-13Cr	2.96Cr
Change In Accounts Receivable	5.1Cr	3.99Cr	5.26Cr	3.47Cr	78Cr
Change In Inventories	16Cr	5.38Cr	-55Cr	162.49Cr	151.92Cr
Change In Accounts Payable	-6.9Cr	-1.84Cr	34Cr	-133.54Cr	44Cr
Change In Income Taxes	-5.87Cr	6.29Cr	-32Cr	-24Cr	186.53Cr
Change In Deferred Taxes	5.41Cr	-8.43Cr	20Cr	-	-10Cr
Change in Other Net Operating Assets	-11Cr	-7.37Cr	-46Cr	127.56Cr	26Cr
Cash from Operations	3Cr	4.93Cr	15Cr	55Cr	41Cr
Capital Expenditure	-21.44L	-2.65Cr	-5.3Cr	-1.04Cr	-1.21Cr
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-21.44L	-2.65Cr	-5.3Cr	-1.04Cr	-1.21Cr
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-4.32Cr	-2.71Cr	-4.03Cr	-51Cr	-84Cr
Total Debt Repaid	-4.32Cr	-2.71Cr	-4.03Cr	-51Cr	-84Cr
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	-4.32Cr	-2.71Cr	-4.03Cr	-51Cr	-84Cr
Net Change in Cash	-1.53Cr	-43.52L	5.88Cr	2.61Cr	-44Cr
Supplemental Items
Levered Free Cash Flow	-3.93Cr	15Cr	-111.74Cr	285.83Cr	162.91Cr
Unlevered Free Cash Flow	-1.77Cr	26Cr	-81Cr	324.93Cr	266.08Cr
Change In Net Working Capital	5.22Cr	-6.93Cr	88Cr	-193Cr	-458.66Cr
Net Debt Issued / Repaid	-4.32Cr	-2.71Cr	-4.03Cr	-51Cr	-84Cr

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Profitability
Return on Assets	1.52	11.91	0.21	12.62	-23.84
Return on Total Capital	3.18	22.19	0.36	20.2	-58.46
Return On Equity %	-11.32	-3.44	34.05	-42.35	-260.63
Return on Common Equity	-10.48	-2.29	36.98	-40.43	-312.88
Margin Analysis
Gross Profit Margin %	28.19	46.16	28.65	45.75	-4.47
SG&A Margin	26.09	24.66	25.53	22.31	38.24
EBITDA Margin %	5.72	23.1	2.71	24.55	-49.61
EBITA Margin %	2.76	19.54	0.51	22.81	-52.61
EBIT Margin %	2.76	19.46	0.35	22.61	-52.61
Income From Continuing Operations Margin %	-3.06	-0.99	12.54	-19.4	-70.49
Net Income Margin %	-2.5	-0.59	12.43	-17.13	-71.8
Net Avail. For Common Margin %	-2.5	-0.59	12.43	-17.13	-71.8
Normalized Net Income Margin	-5.17	0.24	4.23	-8.45	-44.87
Levered Free Cash Flow Margin	-5.03	11.26	-24.68	34.54	25.44
Unlevered Free Cash Flow Margin	-2.26	18.93	-17.97	39.27	41.55
Asset Turnover
Asset Turnover	0.88	0.98	0.98	0.89	0.72
Fixed Assets Turnover	3.9	3.98	4.34	4.19	3.1
Receivables Turnover (Average Receivables)	4.57	5.22	6.19	5.45	4.04
Inventory Turnover (Average Inventory)	1.49	1.34	1.69	1.14	1.99
Short Term Liquidity
Current Ratio	2	1.83	2.1	1.79	0.87
Quick Ratio	0.92	0.8	0.93	0.83	0.4
Operating Cash Flow to Current Liabilities	0.11	0.09	0.08	0.17	0.06
Days Sales Outstanding (Average Receivables)	79.78	69.97	58.95	67.13	90.32
Days Outstanding Inventory (Average Inventory)	244.23	273.13	216.1	322.03	183.73
Average Days Payable Outstanding	113.16	82.66	60.73	146.32	49.79
Cash Conversion Cycle (Average Days)	210.85	260.44	214.32	242.84	224.26
Long Term Solvency
Total Debt/Equity	95.88	86.12	49.51	57.38	-275.57
Total Debt / Total Capital	48.95	46.27	33.11	36.46	156.96
LT Debt/Equity	86.41	73.92	28.64	26.15	-176.94
Long-Term Debt / Total Capital	44.12	39.71	19.16	16.62	100.78
Total Liabilities / Total Assets	73.35	70.29	58.59	59.78	106.79
EBIT / Interest Expense	0.62	1.59	0.03	2.99	-2.04
EBITDA / Interest Expense	1.29	1.88	0.25	3.25	-1.92
(EBITDA - Capex) / Interest Expense	1.23	1.73	0.14	3.23	-1.93
Total Debt / EBITDA	4.27	1.09	8.43	0.86	-0.46
Net Debt / EBITDA	3	0.75	5.24	0.42	-0.23
Total Debt / (EBITDA - Capex)	4.49	1.19	14.84	0.86	-0.45
Net Debt / (EBITDA - Capex)	3.15	0.82	9.23	0.43	-0.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.3	-9.82	5.9	-16.08	-41.17
Gross Profit, 1 Yr. Growth %	-24.1	47.66	-34.28	34.04	-105.74
EBITDA, 1 Yr. Growth %	-63.21	264.32	-87.24	1.34T	-221.2
EBITA, 1 Yr. Growth %	-77.57	539.14	-97.35	-1.06T	-255.37
EBIT, 1 Yr. Growth %	-77.57	536.54	-98.2	5.34T	-236.91
Earnings From Cont. Operations, 1 Yr. Growth %	12.89	-70.85	-1.44T	-229.8	113.77
Net Income, 1 Yr. Growth %	-23.75	-78.76	-2.33T	-215.62	146.6
Normalized Net Income, 1 Yr. Growth %	-16.91T	-104.27	411.75	-267.48	212.54
Diluted EPS Before Extra, 1 Yr. Growth %	-23.75	-78.76	-2.33T	-215.62	146.6
Accounts Receivable, 1 Yr. Growth %	-25.96	-14.08	-6.95	-2.26	-39.45
Inventory, 1 Yr. Growth %	-34.31	-9.27	33.43	-34.12	-36.81
Net Property, Plant and Equip., 1 Yr. Growth %	-13.95	-9.11	4.09	-29.74	-7.03
Total Assets, 1 Yr. Growth %	-26.72	-7.4	20.13	-31.32	-21.93
Tangible Book Value, 1 Yr. Growth %	-9.87	4.3	69.78	-31.34	-121.4
Common Equity, 1 Yr. Growth %	-9.89	5.21	69.45	-31.82	-121.4
Cash From Operations, 1 Yr. Growth %	-54.44	-15.63	-0.78	65.24	-43.1
Capital Expenditures, 1 Yr. Growth %	-28.32	535.23	-35.84	-91.01	-11.08
Levered Free Cash Flow, 1 Yr. Growth %	-232.62	-160.81	103.59	-168.35	-19.09
Unlevered Free Cash Flow, 1 Yr. Growth %	-129.29	-222.52	268.16	-192.3	5.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.07	27.61	72.45	39.11	-19.41
Gross Profit, 2 Yr. CAGR %	8.12	47.76	73.84	38.5	-68.18
EBITDA, 2 Yr. CAGR %	32.42	61.6	18.69	45.38	374.25
EBITA, 2 Yr. CAGR %	-30.41	67.13	-25.65	46.89	313.53
EBIT, 2 Yr. CAGR %	-30.42	66.78	-38.68	46.19	890.1
Earnings From Cont. Operations, 2 Yr. CAGR %	-54.42	-19.93	249.3	516.35	91.06
Net Income, 2 Yr. CAGR %	-59.86	-43.83	284.26	649.7	93.66
Normalized Net Income, 2 Yr. CAGR %	-27.02	273.93	56	332.02	162.41
Diluted EPS Before Extra, 2 Yr. CAGR %	-59.86	-43.83	284.26	649.7	93.66
Accounts Receivable, 2 Yr. CAGR %	5.73	11.32	57.79	40.73	-11.77
Inventory, 2 Yr. CAGR %	-1.82	7.75	94.16	38.35	-26
Net Property, Plant and Equip., 2 Yr. CAGR %	8.64	23.42	71.64	26.19	-7.3
Total Assets, 2 Yr. CAGR %	5.1	14.97	86.12	34.04	-16.02
Tangible Book Value, 2 Yr. CAGR %	11.36	35.32	134.83	59.33	-56.04
Common Equity, 2 Yr. CAGR %	11.38	35.9	135.63	58.62	-56.19
Cash From Operations, 2 Yr. CAGR %	-28.85	-13.47	61.46	88.95	11.22
Capital Expenditures, 2 Yr. CAGR %	-53.31	197.82	256.25	-64.57	-67.58
Levered Free Cash Flow, 2 Yr. CAGR %	12.84	128.4	109.64	128.2	-37.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.14	107.53	95.86	283.43	-13.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	37.77	34.79	75.12	75.82	14.41
Gross Profit, 3 Yr. CAGR %	38.06	49.81	64.71	106.62	-47.47
EBITDA, 3 Yr. CAGR %	2.22	131.74	0.32	185.72	48.97
EBITA, 3 Yr. CAGR %	-16.22	82.01	-37.72	255.6	56.74
EBIT, 3 Yr. CAGR %	-16.22	81.75	-45.23	254.53	56.72
Earnings From Cont. Operations, 3 Yr. CAGR %	35.73	-50.96	199.37	225.5	374.49
Net Income, 3 Yr. CAGR %	190.51	-59.45	179.91	233.75	467.04
Normalized Net Income, 3 Yr. CAGR %	426.31	-64.62	827.14	107.04	324.94
Diluted EPS Before Extra, 3 Yr. CAGR %	190.51	-59.45	179.91	233.75	467.04
Accounts Receivable, 3 Yr. CAGR %	5.62	23.22	53.13	74.34	16.41
Inventory, 3 Yr. CAGR %	30.84	19.43	68.97	75.53	16.74
Net Property, Plant and Equip., 3 Yr. CAGR %	32.83	27.84	70.28	65.18	24.88
Total Assets, 3 Yr. CAGR %	26.78	25.83	70.37	73.04	22.65
Tangible Book Value, 3 Yr. CAGR %	11.48	36.08	113.13	102.02	-10.59
Common Equity, 3 Yr. CAGR %	11.49	36.49	113.6	102.01	-10.86
Cash From Operations, 3 Yr. CAGR %	10.75	-5.95	32.26	110.9	38.77
Capital Expenditures, 3 Yr. CAGR %	12.48	39.21	160.71	35.42	-47.24
Levered Free Cash Flow, 3 Yr. CAGR %	56.8	71.1	235.32	124.02	43.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	-3.76	151.72	138.02	148.35	129.19
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	36.11	38.04	72.22	71.32	50
Gross Profit, 5 Yr. CAGR %	29.6	68	72.99	82.21	-0.3
EBITDA, 5 Yr. CAGR %	18.4	58.72	24	140.03	92.09
EBITA, 5 Yr. CAGR %	5.44	43.35	-8.73	111.6	103.7
EBIT, 5 Yr. CAGR %	5.44	43.22	-15.5	111.21	103.7
Earnings From Cont. Operations, 5 Yr. CAGR %	15.43	-21.27	126.36	69.41	192.27
Net Income, 5 Yr. CAGR %	14	-29.89	271.25	63.46	182.25
Normalized Net Income, 5 Yr. CAGR %	40.25	-31.06	269.75	55.9	553.85
Diluted EPS Before Extra, 5 Yr. CAGR %	14	-29.89	271.25	63.46	182.25
Accounts Receivable, 5 Yr. CAGR %	17.43	18.89	41.71	63.09	43.51
Inventory, 5 Yr. CAGR %	33.44	34.61	75.07	58.97	41.9
Net Property, Plant and Equip., 5 Yr. CAGR %	42.09	31.12	68.16	59.62	56
Total Assets, 5 Yr. CAGR %	30.45	29.79	68.91	61.97	50
Tangible Book Value, 5 Yr. CAGR %	18.5	18.54	71.61	81.91	32.44
Common Equity, 5 Yr. CAGR %	18.5	18.75	71.85	81.91	32.43
Cash From Operations, 5 Yr. CAGR %	13.6	69.58	47.15	56.03	44.18
Capital Expenditures, 5 Yr. CAGR %	-32.89	54.51	103.83	1.07	32.32
Levered Free Cash Flow, 5 Yr. CAGR %	16.6	11.7	155.83	147.36	122.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.21	23.93	110.21	188.37	113.25